Australia markets closed

Actinogen Medical Limited (ACW.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0260-0.0010 (-3.70%)
At close: 04:10PM AEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
12,468
8,900
8,215
2,406
5,537
Selling general and administrative
7,066
6,568
4,558
3,111
2,213
Total operating expenses
19,950
15,873
13,173
5,904
8,912
Operating income or loss
-19,950
-15,873
-13,173
-5,904
-8,912
Interest expense
17.653
16.599
18.479
22.318
28.882
Total other income/expenses net
4,760
4,771
3,653
1,984
3,516
Income before tax
-14,870
-10,752
-9,497
-3,915
-5,331
Income tax expense
0
0
0
0
0
Income from continuing operations
-14,870
-10,752
-9,497
-3,915
-5,331
Net income
-14,870
-10,752
-9,497
-3,915
-5,331
Net income available to common shareholders
-14,870
-10,752
-9,497
-3,915
-5,331
Basic EPS
-0.01
-0.01
-0.01
-0.00
-0.00
Diluted EPS
-0.01
-0.01
-0.01
-0.00
-0.00
Basic average shares
1,875,607
1,901,606
1,812,459
1,483,203
1,204,158
Diluted average shares
1,875,607
1,901,606
1,812,459
1,483,203
1,204,158